Correction to: Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment

被引:0
|
作者
Andrea Darzi
Manale Harfouche
Thurayya Arayssi
Samar Alemadi
Khalid A. Alnaqbi
Humeira Badsha
Farida Al Balushi
Bassel Elzorkany
Hussein Halabi
Mohammed Hamoudeh
Wissam Hazer
Basel Masri
Mohammed A. Omair
Imad Uthman
Nelly Ziade
Jasvinder A. Singh
Robin Christiansen
Peter Tugwell
Holger J. Schünemann
Elie A. Akl
机构
[1] American University of Beirut,AUB GRADE Center, Clinical Research Institute
[2] Weill Cornell Medicine-Qatar- Department of Internal Medicine,Department of Rheumatology
[3] Medical Institute,Department of Rheumatology
[4] Al Ain Hospital,Division of Rheumatology, Department of Medicine
[5] Dr. Humeira Badsha Medical Center,Faculty of Medicine
[6] Rheumatologist City Hospital,Department of Medicine at School of Medicine, and Division of Epidemiology at School of Public Health
[7] Rheumatologist Neurospinal Hospital,Musculoskeletal Statistics Unit, The Parker Institute
[8] Ministry of Health,Department of Medicine
[9] Cairo University,Department of Medicine
[10] Rheumatology Division,Department of Health Research Methods, Evidence, and Impact (HE&I)
[11] Department of Internal Medicine,Department of Internal Medicine
[12] King Faisal Specialist Hospital and Research Center,undefined
[13] Hamad Medical Corporation,undefined
[14] Aspetar,undefined
[15] Jordan Hospital,undefined
[16] King Saud University,undefined
[17] American University of Beirut,undefined
[18] Univeristé Saint Joseph,undefined
[19] Medicine Service and Center for Surgical Medical Acute care Research and Transitions,undefined
[20] VA Medical Center,undefined
[21] University of Alabama,undefined
[22] Bispebjerg and Frederiksberg Hospital,undefined
[23] University of Ottawa,undefined
[24] McMaster University,undefined
[25] McMaster University,undefined
[26] American University of Beirut,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Recommendations in the American College of Rheumatology guideline for the treatment of rheumatoid arthritis related to the use of biologic agents in patients with a history of cancer need reconsideration: comment on the article by Singh et al Reply
    Singh, Jasvinder A.
    Saag, Kenneth S.
    Bridges, S. Louis, Jr.
    Sanchez, William
    McAlindon, Timothy
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (05) : 1316 - 1318
  • [42] Recommendations in the American College of Rheumatology guideline for the treatment of rheumatoid arthritis related to the use of biologic agents in patients with a history of cancer need reconsideration: comment on the article by Singh et al Reply
    Singh, Jasvinder A.
    Saag, Kenneth S.
    Bridges, S. Louis, Jr.
    Sanchez, William
    McAlindon, Timothy
    ARTHRITIS CARE & RESEARCH, 2016, 68 (05) : 725 - 726
  • [43] Occupational Therapy Is a Vital Member of the Interprofessional Team-Based Approach for the Management of Rheumatoid Arthritis: Applying the 2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis
    Baker, Nancy A. A.
    Carandang, Kristine
    Dodge, Carole
    Poole, Janet L. L.
    ARTHRITIS CARE & RESEARCH, 2023,
  • [44] Adverse Event Reporting Rates and Placebo/Standard-of-Care-Arm American College of Rheumatology Responses Vary By Region in Rheumatoid Arthritis Trials
    Tuckwell, Katie
    Teng, Edmond
    Chia, Jenny
    Lee, Daisy
    Galanter, Joshua
    Peake, Jodie
    Keebler, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [45] Level of the Indication of Biologic Agents in the 2012 American College of Rheumatology Recommendations for the Treatment of Rheumatoid Arthritis: Comment on the Article by Singh et al
    Graudal, Niels
    Jurgens, Gesche
    ARTHRITIS CARE & RESEARCH, 2013, 65 (05) : 832 - 832
  • [46] American College of Rheumatology hybrid measure for assessing efficacy of treatment in patients with refractory rheumatoid arthritis: comment on the article by Genovese et al
    Felson, David T.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : 3181 - 3182
  • [47] 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis
    Singh, Jasvinder A.
    Furst, Daniel E.
    Bharat, Aseem
    Curtis, Jeffrey R.
    Kavanaugh, Arthur F.
    Kremer, Joel M.
    Moreland, Larry W.
    O'Dell, James
    Winthrop, Kevin L.
    Beukelman, Timothy
    Bridges, S. Louis, Jr.
    Chatham, W. Winn
    Paulus, Harold E.
    Suarez-Almazor, Maria
    Bombardier, Claire
    Dougados, Maxime
    Khanna, Dinesh
    King, Charles M.
    Leong, Amye L.
    Matteson, Eric L.
    Schousboe, John T.
    Moynihan, Eileen
    Kolba, Karen S.
    Jain, Archana
    Volkmann, Elizabeth R.
    Agrawal, Harsh
    Bae, Sangmee
    Mudano, Amy S.
    Patkar, Nivedita M.
    Saag, Kenneth G.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (05) : 625 - 639
  • [48] THE CONSISTENCY OF US REAL-WORLD RHEUMATOID ARTHRITIS DISEASE-MODIFYING ANTIRHEUMATIC DRUG TREATMENT PATTERNS WITH AMERICAN COLLEGE OF RHEUMATOLOGY GUIDELINES
    Dore, R. K.
    Antonova, J.
    Chang, L.
    Huang, H.
    He, J.
    Genovese, M. C.
    VALUE IN HEALTH, 2020, 23 : S385 - S385
  • [49] American College of Rheumatology hybrid measure for assessing efficacy of treatment in patients with refractory rheumatoid arthritis: comment on the article by Genovese et al Reply
    Genovese, Mark C.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : 3182 - 3182
  • [50] Demonstration of response in rheumatoid arthritis patients who are nonresponders according to the American College of Rheumatology 20% criteria: the paradox of beneficial treatment effects in nonresponders in the ATTRACT trial
    Boers, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (11): : 2703 - 2704